Fulminant Idiopathic Intracranial Hypertension (FIH)

Fulminant idiopathic? intracranial hypertension? (FIH) is a rare, rapidly progressive form of idiopathic? intracranial hypertension? (IIH). In IIH, cerebrospinal fluid (CSF) pressure rises inside the skull without any detectable cause such as tumor or infection?. The term “idiopathic” means the origin is unknown, while “intracranial hypertension” refers to increased pressure around the brain. In the fulminant variant, symptoms and signs develop suddenly and worsen dramatically, typically leading to severe vision loss within four weeks of onset. This acute? course occurs in about 2–3 % of IIH cases and carries a high risk of permanent blindness if not treated immediately EyeWikiPubMed.

Fulminant Idiopathic? Intracranial Hypertension? (FIIH) is a rare, aggressive subtype of idiopathic intracranial hypertension characterized by rapidly progressive vision loss and severe pain? in the head or upper neck. সহজ বাংলা: মাথাব্যথা।" data-rx-term="headache" data-rx-definition="Headache means pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।">headache? over a period of less than four weeks, without any identifiable secondary cause such as a tumor or venous thrombosis?. Patients typically present with acute? headache, pulsatile tinnitus (a whooshing sound in the ears), nausea?, and signs of raised intracranial pressure on examination—most notably papilledema and visual field defects. If not recognized and treated promptly, FIIH carries a high risk of permanent blindness owing to sustained optic nerve compression and ischemia? PubMedEyeWiki.

The underlying pathophysiology of FIIH remains incompletely understood. Three leading theories propose (1) excessive production of cerebrospinal fluid (CSF), (2) impaired venous drainage leading to venous hypertension? and reduced CSF absorption, or (3) increased brain tissue water content. These factors result in elevated intracranial pressure (ICP) under the Monro‐Kellie doctrine, which dictates that the rigid cranial vault cannot accommodate increases in any intracranial component (brain tissue, blood, or CSF) without a rise in pressure. In FIIH, focal venous sinus stenosis? may exacerbate raised ICP by creating a positive feedback loop of rising CSF pressure and further venous narrowing WikipediaCleveland Clinic.

Types

Although IIH in general is categorized simply as idiopathic? (primary) or secondary (when a specific cause is found), clinicians recognize three clinical phenotypes:

1. Classic IIH – the usual form, characterized by gradual onset of pain? in the head or upper neck. সহজ বাংলা: মাথাব্যথা।" data-rx-term="headache" data-rx-definition="Headache means pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।">headache? and mild visual changes over weeks to months Cleveland Clinic.

2. Chronic? IIH – when elevated pressure persists for many months or recurs despite treatment, potentially leading to sustained symptoms.

3. Fulminant IIH – the acute?, vision-threatening subtype defined by symptom onset to severe visual loss in under four weeks, with rapid worsening over days and normal neuroimaging aside from signs of elevated CSF pressure PubMedAmerican Academy of Neurology.

In practice, only “classic” and “fulminant” forms guide urgency: fulminant IIH demands immediate intervention to preserve vision.

Causes (Risk Factors)

Because FIH is a subtype of IIH, the same risk factors apply. Although the precise trigger remains unknown, the following 20 factors are associated with increased ICP and IIH development:

1. Female sex (especially women aged 20–50) – more than 90 % of IIH patients are women PMC.

2. Obesity – high body mass index and recent weight gain strongly predispose to IIH PMC.

3. Rapid weight gain – sudden increases in fat mass may alter CSF dynamics.

4. Polycystic ovary syndrome – hormonal imbalances may affect CSF absorption.

5. Addison’s disease (primary adrenal insufficiency) – endocrine abnormalities can influence fluid balance PMC.

6. Hypoparathyroidism – low parathyroid hormone levels are linked to altered intracranial pressure PMC.

7. Growth hormone therapy in children – exogenous GH may increase CSF production PMC.

8. Hypervitaminosis A – excessive vitamin A intake or its derivatives (e.g., isotretinoin) can raise ICP nhs.uk.

9. Tetracycline antibiotics (minocycline, doxycycline) – long-term use is implicated in IIH Wikipedia.

10. Lithium therapy – this mood stabilizer has been reported to trigger intracranial hypertension? nhs.uk.

11. Thyroid? medications (e.g., levothyroxine) – high doses can alter CSF dynamics nhs.uk.

12. Iron-deficiency anemia? – low red blood cell counts may contribute to altered blood viscosity and CSF pressure nhs.uk.

13. Systemic? lupus erythematosus – autoimmunity can affect CSF absorption pathways nhs.uk.

14. Renal? failure – kidney dysfunction may influence fluid retention and CSF balance.

15. Obstructive sleep apnea – intermittent hypoxia and increased thoracic? pressures can raise ICP.

16. Behçet’s disease – a vasculitis that can involve cerebral veins and affect CSF outflow.

17. Corticosteroid withdrawal – abrupt stopping of steroids may reduce CSF reabsorption and trigger rebound hypertension? PubMed.

18. Vitamin B₁₂ deficiency – may contribute via metabolic and hematological changes.

19. Infections (e.g., HIV, Lyme disease) – some infections can indirectly raise ICP.

20. Certain chemotherapeutic agents (e.g., tetracycline derivatives, some antibiotics) – can perturb CSF regulation.

Symptoms

FIH presents with both general signs of elevated intracranial pressure and acute? visual disturbances. Key symptoms include:

1. pain? in the head or upper neck. সহজ বাংলা: মাথাব্যথা।" data-rx-term="headache" data-rx-definition="Headache means pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।">Headache? – often daily, throbbing, worse in the morning, and aggravated by coughing or bending forward Wikipedia.

2. Transient visual obscurations – brief episodes of dimming or “greying out” of vision in one or both eyes.

3. Persistent blurred vision – due to papilledema (optic nerve swelling?).

4. Double vision (diplopia) – commonly horizontal, from sixth nerve palsy Wikipedia.

5. Pulsatile tinnitus – a “whooshing” sound in time with the heartbeat Cleveland Clinic.

6. Nausea? and vomiting? – from acute? rises in CSF pressure.

7. Neck and shoulder pain – referred pain from meninges under tension.

8. Photophobia – light sensitivity often accompanying headache.

9. Dizziness – feeling unsteady or light-headed.

10. Neck stiffness – mild resistance on neck flexion (not full meningismus).

11. Peripheral numbness or tingling – non-specific sensory complaints.

12. Cranial nerve palsies – especially abducens (VIth), sometimes oculomotor (IIIrd) or trochlear (IVth) nerves Wikipedia.

13. Visual field loss – gradual narrowing, particularly peripheral fields.

14. Tinnitus without pulse – generalized ringing possibly from increased ICP.

15. Acute, severe vision loss – hallmark of the fulminant form, often bilateral and rapidly progressive EyeWiki.

Diagnostic Tests

Physical Exam 

1. Neurologic examination – checks mental status, reflexes, strength, coordination, and cranial nerves to identify focal deficits.

2. Fundoscopic exam – direct or indirect ophthalmoscopy to detect papilledema (optic disc swelling) from raised CSF pressure Penn Medicine.

3. Visual acuity testing – measures clarity of vision using standardized charts (e.g., Snellen chart).

4. Confrontation visual field test – clinician compares patient’s peripheral vision to their own to detect field deficits.

5. Vital signs assessment – blood pressure and pulse can reveal hypertension or bradycardia patterns sometimes seen with elevated ICP.

Manual Tests 

6. Lumbar puncture opening pressure measurement – using a manometer, CSF pressure is recorded; an elevated opening pressure (> 25 cm H₂O) supports IIH diagnosis Medscape.

7. Ocular motility examination – manual testing of eye movements in all directions to uncover sixth nerve palsy causing horizontal diplopia.

8. Meningeal signs – Brudzinski’s and Kernig’s signs are checked to rule out concurrent meningitis, though usually negative in IIH nhs.uk.

Laboratory & Pathological Tests 

9. CSF analysis – after measuring opening pressure, CSF fluid is examined for cell count, protein, glucose, and signs of infection; normal composition confirms idiopathic etiology Medscape.

10. Complete blood count (CBC) – checks for anemia or infection that could mimic or contribute to symptoms nhs.uk.

11. Metabolic panel – evaluates electrolytes, kidney and liver function to exclude secondary causes.

12. Vitamin A level – elevated levels suggest hypervitaminosis A as a possible trigger nhs.uk.

Electrodiagnostic Tests 

13. Visual evoked potentials (VEP) – measure electrical responses of the brain to visual stimuli; can detect optic nerve dysfunction from papilledema PMC.

14. Electro-oculography (EOG) – records eye movement potentials to quantify ocular nerve involvement, though used less commonly.

Imaging Tests

15. Magnetic resonance imaging (MRI) of the brain – rules out masses or hydrocephalus, often shows flattened pituitary (empty sella) or distended optic nerve sheaths Medscape.

16. Magnetic resonance venography (MRV) – evaluates venous sinuses to exclude stenosis or thrombosis Medscape.

17. Computed tomography (CT) head – rapid first-line to rule out hemorrhage or mass lesions; typically normal in IIH Wikipedia.

18. CT venography (CTV) – complements CTV by assessing venous outflow pathways for obstruction.

19. Optic nerve ultrasound – measures optic nerve sheath diameter; enlargement correlates with elevated ICP Penn Medicine.

20. Optical coherence tomography (OCT) – high-resolution imaging of the retina and optic nerve head to quantify papilledema severity Penn Medicine.

Non-Pharmacological Treatments

1. Weight Loss through Nutritional Counseling
   Structured diet programs aiming for a 5–10% reduction in body weight can lead to remission of raised ICP by lowering intra-abdominal and thoracic pressures, thereby improving cerebral venous outflow and CSF absorption EyeWikiAmerican Academy of Neurology.

2. Low-Sodium Diet
   Reducing daily sodium intake to < 1500 mg helps decrease fluid retention and intracranial venous pressure, easing CSF dynamics and alleviating headache symptoms EyeWikiWikipedia.

3. Aerobic Exercise
   Regular moderate-intensity activities (e.g., brisk walking for 30 min/day) support weight loss, enhance cardiovascular health, and may modestly improve CSF reabsorption through improved venous return EyeWikiWebEye.

4. Therapeutic Lumbar Puncture
   Removing 20–30 mL of CSF via lumbar puncture can rapidly lower ICP. Repeated taps may be needed in acute phases to preserve vision, though each carries a risk of post‐LP headache and infection WikipediaMedscape.

5. Head-of-Bed Elevation
   Sleeping with the head elevated at 30° reduces morning ICP surges by facilitating venous drainage from the brain Wikipedia.

6. Avoidance of Valsalva Maneuvers
   Steering clear of activities that spike intrathoracic pressure—such as heavy lifting, straining on the toilet, or forceful coughs—prevents transient ICP elevations that can worsen papilledema Wikipedia.

7. Cognitive Behavioral Therapy (CBT)
   CBT aids in stress management and promotes adherence to lifestyle modifications, indirectly supporting weight loss and symptom control in chronic headache disorders EyeWiki.

8. Acupuncture
   Small studies suggest acupuncture may reduce headache frequency and intensity in IIH by modulating central pain pathways and improving cerebral blood flow EyeWiki.

9. Yoga and Mindfulness Meditation
   These practices can ease stress, reduce sympathetic tone, and lower headache frequency without impacting ICP directly EyeWiki.

10. Biofeedback
    Training patients to control physiological responses—such as muscle tension—may help decrease headache severity EyeWiki.

11. Sleep Apnea Management
    Treating obstructive sleep apnea with CPAP improves oxygenation and venous return during sleep, helping stabilize ICP overnight Cleveland Clinic.

12. Physiotherapy for Neck and Shoulder Tension
    Manual therapies relieve myofascial trigger points that can exacerbate headache symptoms, improving overall comfort EyeWiki.

13. Massage Therapy
    Enhances relaxation, reduces stress hormones, and may indirectly help with headache control EyeWiki.

14. Trigger Avoidance
    Identifying and avoiding individual headache triggers (e.g., bright lights, loud noises) can lower headache frequency EyeWiki.

15. Hydration Optimization
    Maintaining euvolemia helps stabilize CSF production; both dehydration and excessive fluids can aggravate headache Wikipedia.

16. Occupational Therapy
    Adapting daily activities to reduce strain and stress supports symptom management and quality of life EyeWiki.

17. Support Groups
    Peer support fosters adherence to lifestyle changes and provides coping strategies for chronic illness EyeWiki.

18. Stress Management Techniques
    Techniques like progressive muscle relaxation lower sympathetic drive, reducing headache intensity EyeWiki.

19. Temperature Regulation
    Avoiding extreme heat or cold that can trigger headaches or induce vasoconstriction improves comfort EyeWiki.

20. Smoking Cessation and Alcohol Moderation
    Both smoking and excessive alcohol intake can alter cerebral blood flow and worsen headache patterns; cessation is advised EyeWiki.

Drug Treatments

1. Acetazolamide (Carbonic Anhydrase Inhibitor)
   Dosage: Start 500 mg twice daily, titrate up to 2 g/day.
   Purpose & Mechanism: Reduces CSF production by inhibiting carbonic anhydrase in the choroid plexus, lowering ICP by 6–57%.
   Side Effects: Paresthesias, hypokalemia, metabolic acidosis, kidney stones WikipediaPubMed.

2. Furosemide (Loop Diuretic)
   Dosage: 20–40 mg twice daily.
   Purpose & Mechanism: Promotes diuresis to reduce CSF volume; second-line if acetazolamide is not tolerated.
   Side Effects: Electrolyte imbalance, dehydration, renal impairment Wikipedia.

3. Topiramate (Anticonvulsant)
   Dosage: 25 mg twice daily, up to 100 mg/day.
   Purpose & Mechanism: Provides headache prophylaxis via GABA potentiation and carbonic anhydrase inhibition.
   Side Effects: Cognitive slowing, weight loss, paresthesia Wikipedia.

4. Methazolamide (Sulfonamide Diuretic)
   Dosage: 50 mg twice daily.
   Purpose & Mechanism: Similar to acetazolamide but longer half-life; reduces CSF production.
   Side Effects: Similar to acetazolamide, plus sulfonamide reactions Wikipedia.

5. Mannitol (Osmotic Diuretic)
   Dosage: 1 g/kg IV over 30 min; repeat every 6–8 h in acute crises.
   Purpose & Mechanism: Increases plasma osmolality to draw water from brain tissue, rapidly lowering ICP.
   Side Effects: Electrolyte disturbances, dehydration, acute kidney injury Pharmacy JoeWikipedia.

6. Methylprednisolone (Corticosteroid)
   Dosage: 1 g IV daily for 3–5 days in fulminant cases.
   Purpose & Mechanism: Reduces inflammation and capillary permeability; use is controversial and reserved for vision-threatening edema.
   Side Effects: Hyperglycemia, immunosuppression, mood changes Wikipedia.

7. Amiloride (Potassium-Sparing Diuretic)
   Dosage: 5 mg daily.
   Purpose & Mechanism: Reduces CSF production via sodium channel blockade; used off-label.
   Side Effects: Hyperkalemia, renal dysfunction Medsafe.

8. Octreotide (Somatostatin Analog, Experimental)
   Dosage: 50 µg SC three times daily.
   Purpose & Mechanism: May reduce CSF secretion via somatostatin receptor–mediated effects; limited data.
   Side Effects: Gastrointestinal upset, gallstones UpToDate.

9. Spironolactone (Aldosterone Antagonist)
   Dosage: 25 mg daily.
   Purpose & Mechanism: Diuretic effect reduces CSF volume; theoretical benefit.
   Side Effects: Gynecomastia, hyperkalemia Medsafe.

10. GLP-1 Receptor Agonists (e.g., Liraglutide)
    Dosage: Start 0.6 mg SC daily, up to 3.0 mg.
    Purpose & Mechanism: Promotes weight loss by appetite suppression, indirectly lowering ICP.
    Side Effects: Nausea, pancreatitis risk BioMed Central.

Dietary Molecular Supplements

1. Magnesium Citrate 200 mg twice daily
   Promotes vascular relaxation and reduces migraine-like headaches in IIH by modulating NMDA receptors and nitric oxide production Spinal CSF Leak FoundationHealth.

2. Omega-3 Fatty Acids (EPA + DHA) 1 g daily
   Anti-inflammatory effect stabilizes endothelial function and may support cerebral blood flow PMCHealth.

3. Vitamin D₃ 2000 IU daily
   Modulates immune response and reduces chronic inflammation that may worsen headache symptoms Health.

4. Coenzyme Q₁₀ 100 mg twice daily
   Supports mitochondrial energy production in neural tissues and counters oxidative stress Health.

5. Riboflavin (Vitamin B₂) 400 mg daily
   Improves mitochondrial function and can decrease headache frequency F1000Research.

6. Folic Acid 400 µg daily
   Facilitates homocysteine metabolism to support vascular health and reduce headache risk F1000Research.

7. Vitamin E 200 IU daily
   Lipid-soluble antioxidant that protects neural membranes from oxidative damage F1000Research.

8. Alpha-Lipoic Acid 300 mg daily
   Regenerates endogenous antioxidants (e.g., glutathione) and mitigates oxidative stress in neural tissue PMC.

9. Melatonin 3 mg nightly
   Regulates sleep-wake cycle, reduces nocturnal headache frequency, and provides antioxidant effects Health.

10. L-Arginine 3 g daily
    Serves as a substrate for nitric oxide synthesis, improving cerebral perfusion and reducing vascular headache triggers Health.

Experimental Regenerative/Stem Cell Therapies

1. Mesenchymal Stem Cell (MSC) Exosomes
   Dosage: Equivalent to 1×10⁸ MSC‐derived exosomes IV monthly.
   Mechanism: Deliver microRNAs and growth factors to enhance neuroprotection and repair CSF absorption pathways PMC.

2. Autologous Bone Marrow-Derived MSCs
   Dosage: 1×10⁶ cells injected intrathecally.
   Mechanism: Promote remyelination and modulate neuroinflammation to preserve optic nerve function PMC.

3. Umbilical Cord Blood Mononuclear Cells
   Dosage: 1×10⁷ cells intrathecal once.
   Mechanism: Provide trophic support and immunomodulation to protect neural tissues PMC.

4. Intranasal Neural Stem Cells
   Dosage: 1×10⁶ cells via nasal administration.
   Mechanism: Bypass blood-brain barrier to deliver repair cells directly to CSF spaces BioMed Central.

5. Erythropoietin (EPO)
   Dosage: 30,000 IU SC weekly.
   Mechanism: Exhibits neuroprotective and anti-apoptotic effects on optic nerve cells Nature.

6. Granulocyte Colony-Stimulating Factor (G-CSF)
   Dosage: 5 µg/kg IV daily for 3 days.
   Mechanism: Mobilizes endogenous stem cells and modulates neuroinflammation Nature.

Surgical Procedures

1. Optic Nerve Sheath Fenestration
   A microsurgical incision in the optic nerve sheath behind the eye diverts CSF into the orbit, rapidly relieving papilledema and preserving vision in cases of vision-threatening edema Wikipedia.

2. Lumboperitoneal Shunt
   A silicone catheter placed from the lumbar subarachnoid space to the peritoneal cavity diverts CSF, lowering ICP. It is often used when visual symptoms predominate and medical therapy fails Wikipedia.

3. Ventriculoperitoneal Shunt
   A catheter from a cerebral ventricle to the peritoneum drains CSF under a programmable valve, providing long-term ICP control, especially when lumbar taps are insufficient Wikipedia.

4. Transverse Sinus Stenting
   Endovascular deployment of a self‐expanding stent across a stenosed transverse sinus improves venous outflow and CSF absorption, offering an alternative to shunting in select fulminant cases PubMed.

5. Bariatric Surgery
   Procedures such as gastric bypass induce significant weight loss (> 10%), leading to remission of IIH in most patients by reducing obesity-related intracranial venous hypertension JAMA Network.

Prevention Strategies

1. Maintain a healthy weight (BMI < 25 kg/m²) to reduce venous hypertension EyeWiki.

2. Adhere to a low-sodium diet (< 1500 mg/day) to minimize fluid retention EyeWiki.

3. Engage in regular aerobic exercise to support venous return EyeWiki.

4. Avoid medications known to induce intracranial hypertension (e.g., isotretinoin, tetracyclines, growth hormone, lithium) MedlinePlus.

5. Manage endocrine disorders (e.g., PCOS, Cushing syndrome) under medical supervision MedlinePlus.

6. Treat obstructive sleep apnea with CPAP to stabilize nocturnal ICP Cleveland Clinic.

7. Limit vitamin A intake from supplements and high-vitamin A foods (e.g., liver) MedlinePlus.

8. Avoid strenuous Valsalva maneuvers (heavy lifting, straining) Wikipedia.

9. Monitor and adjust thyroid hormone therapy carefully in hypothyroid children MedlinePlus.

10. Undergo regular ophthalmologic screening if at high risk, to detect early papilledema PubMed.

When to See a Doctor

Seek immediate medical attention if you experience sudden or worsening headache, any change in vision (blurred vision, visual field loss, double vision), pulsatile tinnitus, or persistent nausea and vomiting. Early referral to neurology and ophthalmology is critical to prevent irreversible vision loss PubMedCleveland Clinic.

Dietary Guidelines: What to Eat and What to Avoid

What to Eat (daily):

• Plenty of fresh fruits and vegetables for antioxidants and low glycemic index carbohydrates EyeWiki.

• Lean proteins (fish, poultry, legumes) for muscle health EyeWiki.

• Whole grains rich in fiber for satiety and weight management EyeWiki.

• Healthy fats (olive oil, nuts, avocado) for vascular health Health.

• Low-fat dairy or dairy alternatives for calcium without excess calories Health.

What to Avoid:

• High-sodium processed foods (canned soups, cured meats) that promote fluid retention EyeWiki.

• Vitamin A–rich supplements (e.g., isotretinoin) and excessive liver consumption MedlinePlus.

• Sugary drinks and refined carbohydrates that contribute to weight gain EyeWiki.

• Excessive caffeine and alcohol, both of which can trigger headaches EyeWiki.

• Trans fats and deep-fried foods linked to vascular dysfunction Health.

Frequently Asked Questions

1. What is Fulminant IIH?
   A severe, rapidly progressive form of IIH causing vision loss within four weeks, without secondary cause PubMed.

2. How is Fulminant IIH diagnosed?
   By neuroimaging (normal MRI/MRV), lumbar puncture showing opening pressure > 25 cm H₂O, and rapid vision changes PubMed.

3. What causes Fulminant IIH?
   The exact cause is unknown; obesity, venous sinus stenosis, and impaired CSF absorption are implicated WikipediaEyeWiki.

4. Can Fulminant IIH be cured?
   Prompt medical and surgical treatment can restore normal ICP and prevent permanent vision loss in many patients PubMed.

5. What is the difference between IIH and Fulminant IIH?
   Fulminant IIH progresses to severe vision loss in < 4 weeks, whereas chronic IIH evolves more slowly PubMedPubMed.

6. Is weight loss effective?
   Yes—achieving ≥ 5–10% weight reduction often leads to remission of symptoms American Academy of Neurology.

7. What first-line drug is used?
   Acetazolamide is the cornerstone, reducing CSF production by blocking carbonic anhydrase Wikipedia.

8. When is surgery needed?
   If vision worsens despite maximal medical therapy, surgeries like ONSF or shunting are indicated PubMed.

9. Are there experimental stem cell treatments?
   Early studies on MSC exosomes and neural stem cells show promise for neuroprotection in other conditions, but data in IIH are very limited PMCPMC.

10. What are common side effects of acetazolamide?
    Paresthesia, kidney stones, metabolic acidosis, and hypokalemia Wikipedia.

11. Can children get Fulminant IIH?
    Yes, though it is rare; pediatric cases require tailored weight and hormone management EyeWiki.

12. Is pregnancy safe?
    Pregnancy may worsen IIH; close monitoring and avoiding contraindicated drugs (e.g., acetazolamide) are essential Mayo Clinic.

13. Should I avoid vitamin A?
    Yes—high doses from supplements or isotretinoin greatly increase risk; consult your doctor MedlinePlus.

14. Can Fulminant IIH recur?
    Recurrence is possible if risk factors (e.g., obesity) are not addressed and CSF pressure rises again PubMed.

15. When should I head to the ER?
    For sudden vision loss, severe unremitting headache, or new neurological deficits, seek emergency care immediately PubMedCleveland Clinic.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 04, 2025.